Newsroom archive

04 . 02 .2021
Press release
Galderma receives FDA approval for Restylane® Defyne for chin augmentation
  • Global release
READ MORE
26 . 01 .2021
Press release
Galderma Announces Launch of Face for Change Program
  • U.S. release
READ MORE
18 . 11 .2020
Press release
Galderma launches Dysport® in China for treatment of glabellar lines
  • Global release
READ MORE
17 . 11 .2020
Press release
Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)
  • Global release
READ MORE
13 . 10 .2020
Press release
Cetaphil Taps Rachel Brosnahan as Creative Consultant for New “Up Close and Sensitive” Digital Campaign
  • U.S. release
READ MORE
09 . 10 .2020
Press release
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
  • Global release
READ MORE
07 . 10 .2020
Press release
Cetaphil® Unveils Premium Product Line with New HydroSensitiv™ Complex That Delivers 48-Hour Hydration
  • U.S. release
READ MORE
06 . 07 .2020
Press release
On International Kissing Day, Galderma Shares First-of-its-Kind Phase IV Kissability Study Results Showing Both Subject and Partner Satisfaction with Restylane® Kysse
  • U.S. release
READ MORE
10 . 06 .2020
Press release
Galderma global research reveals struggles of people with rosacea and psoriasis of the face experiencing a lack of control and impact on mental wellbeing
  • Global release
READ MORE
12 . 05 .2020
Press release
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
  • Global release
READ MORE